Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: NPT, BLK, DEI

ENRICHHER BEGINS NEW YEAR WITH $5,000 SMALL BUSINESS GRANT TARGETING WOMEN AND FOUNDERS OF COLOR


ATLANTA, Jan. 13, 2022 /PRNewswire/ -- EnrichHER, the only Black woman-owned fintech lender serving women and founders of color, will launch its next $5,000 small business grant contest this month.

EnrichHER's grant is a financial lifeline for businesses with operations needs such as equipment, marketing or payroll.

As inflation, COVID-19 and labor shortages continue to complicate today's economy, small business owners are under tremendous pressure to manage and grow their businesses. The $5,000 EnrichHER Grant serves as a lifeline for founders seeking funds for operational needs such as new equipment, a marketing campaign or payroll support.

EnrichHER will begin accepting applications Thursday, January 20, 2022 until Thursday, February 3, 2022 at enrichher.com/grant. A grant winner will be chosen and announced on Wednesday, March 31, 2022. Applicants must be a U.S.-based business owned by a woman or person of color.

"I'm excited to begin the new year with an opportunity that will help New Majority founders reach their 2022 business goals," says Dr. Roshawnna Novellus, founder and CEO of EnrichHER, which to date has connected businesses to $14MM in capital. "Despite the challenges businesses led by women and people of color face, these owners are growing and managing companies that are stabilizing our economy and providing consumers with much-needed goods and services. Their survival is crucial to our community's ability to get through these uncertain times. I am proud that EnrichHER is playing a role in empowering this demographic of entrepreneurs."

In addition to a chance to win the EnrichHER grant, applicants will receive information on financing options, the EnrichHER Accelerator Program, as well as access to a weekly newsletter providing over $50,000 in grant opportunities and pitch competitions weekly.

For more information, visit enrichher.com/grant.

ABOUT ENRICHHER
EnrichHER is a financial technology platform that matches revenue-generating companies led by women and founders of color to individual and institutional sources of funding. A Certified B Corporationtm and portfolio company of Techstars, Fearless Fund, and Georgia Tech's ATDC Accelerate program, EnrichHER has been in-market since 2019, deploying $14M in capital to traditional businesses from 47 states. Our network has engaged with over 98,000 companies through our digital community and in-person activations. Named one of Atlanta Business Chronicle's 2021 "Atlanta Startups to Watch" and winner of the FinTech South Challenge, EnrichHER is proud to fuel the fastest-growing demographics of business owners -- Black women and diverse-led companies -- by providing capital, coaching, and connections.

SOCIAL
IG: @ienrichher
TW: @ienrichher
LinkedIn: EnrichHER
Facebook: @iEnrichHER

Media Contact:
Saptosa Foster                                                 
[email protected] 

SOURCE EnrichHER


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: